» Articles » PMID: 35170213

Mesenchymal Stem Cells Augment Regulatory T Cell Function Via CD80-mediated Interactions and Promote Allograft Survival

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2022 Feb 16
PMID 35170213
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) and regulatory T cells (Tregs) both have been shown to modulate the alloimmune response and promote transplant survival. Mounting evidence suggests that MSCs augment Treg function, but the mechanisms underlying this phenomenon have not been fully deciphered. Here, we identified that MSCs express substantial levels of CD80 and evaluated its immunoregulatory function using in vivo and in vitro experiments. Our in vitro culture assays demonstrated that MSCs induce expression of FoxP3 in Tregs in a contact-dependent manner, and the blockade of CD80 abrogates this FoxP3 induction and Treg-mediated suppression of T cell proliferation. Moreover, supplementation of soluble CD80 significantly upregulated FoxP3 expression. Using a well-characterized murine model of corneal transplantation, we show that silencing CD80 in MSCs diminishes the capacity of MSCs to promote selective graft infiltration of Tregs, promote FoxP3 expression and upregulate suppressive function of Tregs. Consequently, MSCs, following CD80 knockdown, failed to promote corneal allograft survival.

Citing Articles

Mechanism and application of mesenchymal stem cells and their secreting extracellular vesicles in regulating CD4T cells in immune diseases.

Lin Z, Cai W, Sun Y, Han B, Hu Y, He Z Biophys Rep. 2025; 10(6):403-415.

PMID: 39758422 PMC: 11693500. DOI: 10.52601/bpr.2024.240005.


Mesenchymal stem cell therapy for liver transplantation: clinical progress and immunomodulatory properties.

Wen F, Yang G, Yu S, Liu H, Liao N, Liu Z Stem Cell Res Ther. 2024; 15(1):320.

PMID: 39334441 PMC: 11438256. DOI: 10.1186/s13287-024-03943-6.


Mesenchymal stromal cells protect tissues from Th1 immune responses via IL-11 secretion.

Cho W, Pulimamidi V, Mittal S, Chauhan S FASEB J. 2024; 38(10):e23683.

PMID: 38758184 PMC: 11149610. DOI: 10.1096/fj.202400078R.


Exosomal miR-181d-5p Derived from Rapamycin-Conditioned MDSC Alleviated Allograft Rejection by Targeting KLF6.

Wei C, Sun Y, Zeng F, Chen X, Ma L, Liu X Adv Sci (Weinh). 2023; 10(34):e2304922.

PMID: 37870185 PMC: 10700181. DOI: 10.1002/advs.202304922.


Adult tissue-specific stem cell interaction: novel technologies and research advances.

Luo X, Liu Z, Xu R Front Cell Dev Biol. 2023; 11:1220694.

PMID: 37808078 PMC: 10551553. DOI: 10.3389/fcell.2023.1220694.


References
1.
Hua J, Inomata T, Chen Y, Foulsham W, Stevenson W, Shiang T . Pathological conversion of regulatory T cells is associated with loss of allotolerance. Sci Rep. 2018; 8(1):7059. PMC: 5935752. DOI: 10.1038/s41598-018-25384-x. View

2.
Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E . Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood. 2005; 106(5):1755-61. DOI: 10.1182/blood-2005-04-1496. View

3.
Gao F, Chiu S, Motan D, Zhang Z, Chen L, Ji H . Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. 2016; 7:e2062. PMC: 4816164. DOI: 10.1038/cddis.2015.327. View

4.
Treacy O, OFlynn L, Ryan A, Morcos M, Lohan P, Schu S . Mesenchymal stem cell therapy promotes corneal allograft survival in rats by local and systemic immunomodulation. Am J Transplant. 2014; 14(9):2023-36. DOI: 10.1111/ajt.12828. View

5.
Oh J, Lee R, Yu J, Ko J, Lee H, Ko A . Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response. Mol Ther. 2012; 20(11):2143-52. PMC: 3498800. DOI: 10.1038/mt.2012.165. View